Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

The GIST paradigm: how to establish diagnostic and prognostic criteria.

Calabuig-Farinas S, Lopez-Guerrero JA, Llombart-Bosch A.

Arkh Patol. 2011 Jul-Aug;73(4):13-21. Review.

PMID:
22164425
2.

Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.

Miettinen M, Sobin LH, Lasota J.

Am J Surg Pathol. 2009 Sep;33(9):1267-75. doi: 10.1097/PAS.0b013e3181a13e99.

PMID:
19440146
3.

Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.

Miettinen M, Majidi M, Lasota J.

Eur J Cancer. 2002 Sep;38 Suppl 5:S39-51. Review.

PMID:
12528772
4.

Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases.

Koay MH, Goh YW, Iacopetta B, Grieu F, Segal A, Sterrett GF, Platten M, Spagnolo DV.

Pathology. 2005 Feb;37(1):22-31.

PMID:
15875730
5.

[Morphological characteristics and prognostic criteria for gastrointestinal stromal tumors].

Tsyganova IV, Anurova OA, Mazurenko NN.

Arkh Patol. 2011 Nov-Dec;73(6):37-42. Russian.

PMID:
22379899
6.
7.

[Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy].

Coindre JM, Emile JF, Monges G, Ranchère-Vince D, Scoazec JY.

Ann Pathol. 2005 Oct;25(5):358-85; quiz 357. Review. French.

PMID:
16498290
8.

Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.

Zheng S, Chen LR, Wang HJ, Chen SZ.

Hepatogastroenterology. 2007 Dec;54(80):2285-90.

PMID:
18265649
9.

Evaluation of prognostic factors and their capacity to predict biological behavior in gastrointestinal stromal tumors.

Calabuig-Fariñas S, López-Guerrero JA, Navarro S, Machado I, Poveda A, Pellín A, Llombart-Bosch A.

Int J Surg Pathol. 2011 Aug;19(4):448-61. doi: 10.1177/1066896911402327. Epub 2011 Mar 21.

PMID:
21427092
10.

Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.

Lee HE, Kim MA, Lee HS, Lee BL, Kim WH.

J Clin Pathol. 2008 Jun;61(6):722-9. doi: 10.1136/jcp.2007.052225. Epub 2008 Apr 1.

PMID:
18381383
11.

Histopathology of gastrointestinal stromal tumor.

Miettinen M, Lasota J.

J Surg Oncol. 2011 Dec;104(8):865-73. doi: 10.1002/jso.21945. Review.

PMID:
22069171
12.

Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases.

Lasota J, Corless CL, Heinrich MC, Debiec-Rychter M, Sciot R, Wardelmann E, Merkelbach-Bruse S, Schildhaus HU, Steigen SE, Stachura J, Wozniak A, Antonescu C, Daum O, Martin J, Del Muro JG, Miettinen M.

Mod Pathol. 2008 Apr;21(4):476-84. doi: 10.1038/modpathol.2008.2. Epub 2008 Feb 1.

13.

Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.

Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, Matsuda H, Kitamura Y.

Cancer Res. 1999 Sep 1;59(17):4297-300.

14.

Epithelioid/mixed phenotype in gastrointestinal stromal tumors with KIT mutation from the stomach is associated with accelerated passage of late phases of the cell cycle and shorter disease-free survival.

Haller F, Cortis J, Helfrich J, Cameron S, Schüler P, Schwager S, Gunawan B, Füzesi L, Agaimy A.

Mod Pathol. 2011 Feb;24(2):248-55. doi: 10.1038/modpathol.2010.188. Epub 2010 Sep 10.

15.

DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.

Miettinen M, Wang ZF, Lasota J.

Am J Surg Pathol. 2009 Sep;33(9):1401-8. doi: 10.1097/PAS.0b013e3181a90e1a.

PMID:
19606013
16.

Activating mutations in c-KIT and PDGFRalpha are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes.

Burger H, den Bakker MA, Kros JM, van Tol H, de Bruin AM, Oosterhuis W, van den Ingh HF, van der Harst E, de Schipper HP, Wiemer EA, Nooter K.

Cancer Biol Ther. 2005 Nov;4(11):1270-4. Epub 2005 Nov 18.

PMID:
16294026
17.
18.

c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue).

Yamamoto H, Oda Y, Kawaguchi K, Nakamura N, Takahira T, Tamiya S, Saito T, Oshiro Y, Ohta M, Yao T, Tsuneyoshi M.

Am J Surg Pathol. 2004 Apr;28(4):479-88.

PMID:
15087667
19.

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).

Dematteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR.

Cancer. 2008 Feb 1;112(3):608-15.

20.

KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.

Yamamoto H, Kojima A, Nagata S, Tomita Y, Takahashi S, Oda Y.

Am J Surg Pathol. 2011 Sep;35(9):1287-95. doi: 10.1097/PAS.0b013e3182206f15.

PMID:
21836495

Supplemental Content

Support Center